| Geld/Brief | 2,63 $ / 2,91 $ |
| Spread | +10,65% |
| Schluss Vortag | 2,74 $ |
| Gehandelte Stücke | 3.013 |
| Tagesvolumen Vortag | 50.427,27 $ |
| Tagestief 2,81 $ Tageshoch 2,81 $ | |
| 52W-Tief 1,33 $ 52W-Hoch 3,50 $ | |
| Jahrestief 2,58 $ Jahreshoch 3,22 $ | |
| Umsatz in Mio. | 5,04 $ |
| Operatives Ergebnis (EBIT) in Mio. | -65,01 $ |
| Jahresüberschuss in Mio. | -61,43 $ |
| Umsatz je Aktie | 0,03 $ |
| Gewinn je Aktie | -0,42 $ |
| Gewinnrendite | -42,77% |
| Umsatzrendite | - |
| Return on Investment | -39,13% |
| Marktkapitalisierung in Mio. | 239,20 $ |
| KGV (Kurs/Gewinn) | -3,90 |
| KBV (Kurs/Buchwert) | 1,67 |
| KUV (Kurs/Umsatz) | 54,67 |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +91,50% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| Düsseldorf | 2,24 € | -2,61% | 2,30 € | 12:30 | |
| Frankfurt | 2,24 € | -1,75% | 2,28 € | 08:10 | |
| Hamburg | 2,24 € | -7,44% | 2,42 € | 08:01 | |
| München | 2,30 € | -0,86% | 2,32 € | 09:24 | |
| Stuttgart | 2,28 € | -2,56% | 2,34 € | 15:31 | |
| L&S RT | 2,34 € | +0,86% | 2,32 € | 16:13 | |
| NYSE | 2,75 $ | -1,61% | 2,795 $ | 26.02.26 | |
| Nasdaq | 2,81 $ | +2,55% | 2,74 $ | 15:34 | |
| AMEX | 2,77 $ | +0,73% | 2,75 $ | 17.02.26 | |
| Tradegate | 2,36 € | 0 % | 2,36 € | 26.02.26 | |
| Quotrix | 2,32 € | -1,69% | 2,36 € | 07:27 | |
| Gettex | 2,32 € | -0,85% | 2,34 € | 16:14 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 26.02.26 | 2,74 | 50 T |
| 25.02.26 | 2,785 | 6.858 |
| 24.02.26 | 2,79 | 13.940 |
| 23.02.26 | 2,88 | 4.494 |
| 20.02.26 | 2,79 | 4.307 |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 2,85 $ | -3,86% |
| 1 Monat | 3,18 $ | -13,84% |
| 6 Monate | 1,69 $ | +62,13% |
| 1 Jahr | 1,90 $ | +44,21% |
| 5 Jahre | 2,68 $ | +2,24% |
| Marktkapitalisierung | 316,09 Mio. € |
| Aktienanzahl | 118,88 Mio. |
| Streubesitz | 97,80% |
| Währung | EUR |
| Land | Australien |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | ADR |
| +0,41% | BlackRock Inc |
| +0,25% | Meridian Wealth Management, LLC |
| +0,08% | Sender Co & Partners, Inc. |
| +0,08% | Morgan Stanley - Brokerage Accounts |
| +0,04% | UBS Group AG |
| +0,04% | Steward Partners Investment Advisory, LLC |
| +0,04% | Susquehanna International Group, LLP |
| +0,03% | Dimensional Fund Advisors, Inc. |
| +0,03% | Verition Fund Managegment, LLC |
| +0,02% | LPL Financial Corp |
| +0,02% | Rhumbline Advisers |
| +0,01% | FNY Investment Advisers, LLC |
| +0,01% | Geode Capital Management, LLC |
| +0,01% | XTX Topco Ltd |
| +0,01% | Bank of America Corp |
| +0,01% | HighTower Advisors, LLC |
| +0,00% | Tower Research Capital LLC |
| +0,00% | Royal Bank of Canada |
| +0,00% | GAMMA Investing LLC |
| 0,00% | SIMPLEX TRADING, LLC |
| +1,09% | Weitere |
| +97,80% | Streubesitz |
China-Patent
https://themarketherald.com.au/immutep-asximm-wins-patent-for-cancer-treatment-in-china-2021-05-26/
